Terms: = Testicular cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568
15 results:
1. Efficacy against Lung cancer Is Augmented by Combining Aberrantly N-Glycosylated T Cells with a Chimeric Antigen Receptor Targeting Fragile X Mental Retardation 1 Neighbor.
Toyofuku T; Ishikawa T; Nojima S; Kumanogoh A
J Immunol; 2024 Mar; 212(5):917-927. PubMed ID: 38214607
[TBL] [Abstract] [Full Text] [Related]
2. Specific immune cell and cytokine characteristics of human testicular germ cell neoplasia.
Klein B; Haggeney T; Fietz D; Indumathy S; Loveland KL; Hedger M; Kliesch S; Weidner W; Bergmann M; Schuppe HC
Hum Reprod; 2016 Oct; 31(10):2192-202. PubMed ID: 27609978
[TBL] [Abstract] [Full Text] [Related]
3. Resistance training does not protect against increases in plasma cytokine levels among germ cell cancer patients during and after chemotherapy.
Christensen JF; Tolver A; Andersen JL; Rørth M; Daugaard G; Hojman P
J Clin Endocrinol Metab; 2014 Aug; 99(8):2967-76. PubMed ID: 25050898
[TBL] [Abstract] [Full Text] [Related]
4. The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer.
Hemmerle T; Neri D
Int J Cancer; 2014 Jan; 134(2):467-77. PubMed ID: 23818211
[TBL] [Abstract] [Full Text] [Related]
5. Complications of autologous lymph-node transplantation for limb lymphoedema.
Vignes S; Blanchard M; Yannoutsos A; Arrault M
Eur J Vasc Endovasc Surg; 2013 May; 45(5):516-20. PubMed ID: 23305787
[TBL] [Abstract] [Full Text] [Related]
6. A case-control investigation of immune function gene polymorphisms and risk of testicular germ cell tumors.
Purdue MP; Sakoda LC; Graubard BI; Welch R; Chanock SJ; Sesterhenn IA; Rubertone MV; Erickson RL; McGlynn KA
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):77-83. PubMed ID: 17220333
[TBL] [Abstract] [Full Text] [Related]
7. [A case of granulomatous orchitis].
Tomita Y; Nemoto K
Hinyokika Kiyo; 2006 Oct; 52(10):817-8. PubMed ID: 17131875
[TBL] [Abstract] [Full Text] [Related]
8. Immunopathology of in situ seminoma.
Bols B; Jensen L; Jensen A; Braendstrup O
Int J Exp Pathol; 2000 Jun; 81(3):211-7. PubMed ID: 10971742
[TBL] [Abstract] [Full Text] [Related]
9. [New combination chemotherapy in urological cancers].
Hattori K; Akaza H
Gan To Kagaku Ryoho; 2000 Mar; 27(3):382-7. PubMed ID: 10740631
[TBL] [Abstract] [Full Text] [Related]
10. Histocompatibility leukocyte antigen-A2-restricted and tumor-specific cytotoxic T lymphocytes from tumor-infiltrating lymphocytes of patient with testicular embryonal cancer.
Suekane S; Nakao M; Inoue M; Noda S; Itoh K
Jpn J Cancer Res; 1997 Dec; 88(12):1181-9. PubMed ID: 9473736
[TBL] [Abstract] [Full Text] [Related]
11. [New concepts in systemic chemotherapy].
Harstrick A; Seeber S
Urologe A; 1995 May; 34(3):185-8. PubMed ID: 7610509
[TBL] [Abstract] [Full Text] [Related]
12. Immunological paradox in testicular tumours: the presence of a large number of activated T-cells despite the complete absence of MHC antigens.
Nouri AM; Hussain RF; Oliver RT; Handy AM; Bartkova I; Bodmer JG
Eur J Cancer; 1993; 29A(13):1895-9. PubMed ID: 8260249
[TBL] [Abstract] [Full Text] [Related]
13. Enhancement of lymphokine-activated killer activity induction in vitro by interleukin-1 administered in patients with urological malignancies.
Marumo K; Tachibana M; Deguchi N; Tazaki H
J Immunother (1991); 1992 Apr; 11(3):191-7. PubMed ID: 1515424
[TBL] [Abstract] [Full Text] [Related]
14. Reduction of testosterone synthesis after high dose interleukin-2 therapy of metastatic cancer.
Meikle AW; Cardoso de Sousa JC; Ward JH; Woodward M; Samlowski WE
J Clin Endocrinol Metab; 1991 Nov; 73(5):931-5. PubMed ID: 1834690
[TBL] [Abstract] [Full Text] [Related]
15. [Effects of recombinant interleukin 1 beta on peripheral blood cells and induction of lymphokine-activated killer activity in patients with urological malignancies].
Marumo K; Ueno M; Muraki J; Tachibana M; Deguchi N; Tazaki H
Nihon Hinyokika Gakkai Zasshi; 1991 Aug; 82(8):1211-7. PubMed ID: 1921014
[TBL] [Abstract] [Full Text] [Related]
